Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2025-09-01
2025-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect Of Health Development Behavıour Traınıng In Pregnancyon Sleep Qualıty And Physıcal Actıvıty Levels
NCT07315971
Sexual Function, Body Image, Kinesiophobia and Physical Activity in Pregnant Women
NCT05990361
Obstetric Exercise and Maternal Outcomes in Pregnancy
NCT07170124
Home Visits in Pregnancy and Healthy Lifestyle Behaviors
NCT07061795
The Relationship Between Physical Activity Level and Fear of Birth (Tokophobia) in Pregnant Women
NCT04922346
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
study group
pregnant women
No interventions assigned to this group
control group
healthy non-pregnant women
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Being in the second or third trimester of pregnancy,
3. Being literate in Turkish,
4. Willingness to participate in the study.
1. Being between 18 and 45 years of age,
2. Female sex,
3. Being literate in Turkish,
4. Willingness to participate in the study.
Exclusion Criteria
2. Presence of orthopedic or neurological problems that may hinder participation in the study,
3. Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
4. Multiple pregnancy.
1. Having a disease severe enough to prevent physical activity and exercise (e.g., endocrine and metabolic disorders, cardiopulmonary diseases),
2. Presence of orthopedic or neurological problems that may hinder participation in the study,
3. Presence of visual, auditory, or cognitive impairments severe enough to prevent participation in the study,
4. Participation in another experimental or drug study during the study period,
5. Being pregnant or suspected of pregnancy,
6. Having experienced pregnancy, childbirth, or surgical intervention within the last six months.
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ordu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Semiha Yenişehir
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Semiha Yenişehir
Role: PRINCIPAL_INVESTIGATOR
Ordu University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ordu Üniversitesi
Ordu, Altınordu, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E-1146814
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.